Skip to main content
. 2021 May 10;47(5):1006–1019. doi: 10.1590/S1677-5538.IBJU.2020.1098

Supplemental Table 3. Baseline characteristics of patients before and after propensity-score matching for IC alone vs CUD alone.

Before propensity-score matching After propensity-score matching
IC alone CUD alone Standardized differences IC alone CUD alone Standardized differences
Sample size (n) 431 97 94 94
Age, year 64.1 ±13.8 58.7±14.8 0.38 58.1±14.0 58.6±14.9 -0.03
Sex 0.01 -0.13
Male 236 (54.8) 52 (53.6) 44 (46.8) 50 (53.2)
Female 195 (45.2) 44 (45.4) 50 (53.2) 44 (46.8)
Missing 0 (0) 1 (1.0) 0 0
Race 0.22 0.04
Caucasian 349 (81.0) 86 (88.7) 82 (87.2) 83 (88.3)
African American 32 (7.4) 5 (5.2) 5 (5.3) 5 (5.3)
Other/Unknown 50 (11.6) 6 (6.2) 7 (7.5) 6 (6.4)
BMI 28.3±7.8 27.4±6.9 0.12 26.3±7.5 27.3±6.8 -0.13
ASA category 0.37 0.13
1 - 2 92 (21.4) 37 (38.1) 30 (31.9) 36 (38.3)
3 - 4 339 (78.6) 60 (61.9) 64 (68.1) 58 (61.7)
Cardiac history 13 (3.0) 2 (2.1) 0.06 5 (5.3) 2 (2.1) 0.17
Neurologic history 28 (6.5) 4 (4.1) 0.11 4 (4.3) 4 (4.3) 0
History of COPD 29 (6.7) 6 (6.2) 0.02 5 (5.3) 6 (6.4) -0.04
Diabetes 92 (21.4) 12 (12.4) 0.24 13 (13.8) 11 (11.7) 0.06
Dialysis 5 (1.2) 3 (3.1) -0.13 4 (4.3) 3 (3.2) 0.06
Active smoking 79 (18.3) 25 (25.8) -0.18 27 (28.7) 24 (25.5) 0.07
Pre-operative chemotherapy 4 (0.9) 2 (2.1) -0.01 0 (0) 2 (2.1) -0.04
Pre-operative radiotherapy 1 (0.2) 1 (1.0) -0.02 0 (0) 1 (1.1) -0.07
Chronic steroid use 15 (3.5) 0 (0) 0.27 0 (0) 0 (0) 0
Functional status -0.06 0
Independent 368 (85.4) 83 (85.5) 82 (87.2) 82 (87.2)
Partially or totally dep endent 63 (14.6) 12 (12.4) 12 (12.8) 12 (12.8)
Unknown 0 (0) 2 (2.1) 0 (0) 0 (0)
Total operation time (minutes) 328±138 325±118 0.03 326±142 324±119 0.01